Eurofins Scientific SE (EPA: ERF)
France
· Delayed Price · Currency is EUR | Market Cap | 8.84B |
| Revenue (ttm) | 6.72B |
| Net Income (ttm) | 325.90M |
| Shares Out | 189.35M |
| EPS (ttm) | 1.67 |
| PE Ratio | 27.99 |
| Forward PE | 13.42 |
| Dividend | 0.50 (1.07%) |
| Ex-Dividend Date | Jul 3, 2024 |
| Volume | 164,682 |
| Open | 47.42 |
| Previous Close | 46.69 |
| Day's Range | 45.89 - 47.90 |
| 52-Week Range | 39.47 - 62.10 |
| Beta | 0.68 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 26, 2025 |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, a... [Read more]
Financial Performance
In 2023, Eurofins Scientific SE's revenue was 6.51 billion, a decrease of -2.94% compared to the previous year's 6.71 billion. Earnings were 256.50 million, a decrease of -55.84%.
Financial StatementsNews
Eurofins Scientific SE (ERFSF) Q3 2024 Earnings Call Transcript
Eurofins Scientific: On Track To Generate 1.5B EUR In EBITDA
Eurofins Scientific reported a net profit of 220.7M EUR and an attributable net free cash flow of 217M EUR in H1, supporting its financial health. Read more here.
Eurofins Scientific SE (ERFSF) Q2 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q2 2024 Earnings Call July 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chief Executive Officer Laurent Lebras - Chief Financial Officer Conference Cal...
Eurofins Scientific announces the acquisition of Labormar, further expanding its presence in Latin America and its Food and Feed, Environmental, Cosmetic and Pharmacological testing offering in Colombia
BARRANQUILLA, Colombia--(BUSINESS WIRE)--The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisitio...
Eurofins Scientific's stock drops on allegations from short-seller Muddy Waters
Eurofins Scientific shares plunged on Monday after Muddy Waters Research said in a report it had started shorting the laboratory-services company, alleging founder and Chief Executive Gilles Martin ha...
Eurofins Scientific SE (ERFSF) Q1 2024 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q1 2024 Earnings Conference Call April 24, 2024 9:00 AM ET Company Participants Gilles Martin - Chairman and CEO Conference Call Participants Suhasini Varanasi - G...
Eurofins Scientific SE (ERFSF) Q4 2023 Earnings Call Transcript
Eurofins Scientific SE (ERFSF) Q4 2023 Earnings Call Transcript
Eurofins Scientific Is A Growth Story That Has Reached Fair Valuation Again
Eurofins Scientific is delivering a 10% growth without relying on exuberant COVID-related margins. The company boasts a robust business model, a significant market share, and a reliable and trustworth...
Eurofins Scientific Announces the Acquisition of Quasfar, Establishing a Presence in Colombia and Expanding the Presence of Eurofins Laboratories in Latin America
LUXEMBOURG--(BUSINESS WIRE)--The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced m...
Eurofins Scientific Announces the Acquisition of Labor 3, Further Expanding Its Offering to the Food and Feed Market in Brazil and the Presence of Eurofins Laboratories in Latin America
LUXEMBOURG--(BUSINESS WIRE)--The Eurofins network of companies, the global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced m...
Eurofins Scientific SE (ERFSF) Q3 2023 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q3 2023 Earnings Conference Call October 24, 2023 9:00 AM ET Company Participants Gilles Martin - Chairman and Chief Executive Officer Conference Call Participants...
Eurofins Scientific: The Normalization Of COVID-Related Sales Presents An Opportunity
Eurofins is among the largest laboratory networks in Europe, offering essential services to stable industries such as food and beverages, as well as clinical diagnostics. The company experienced a sub...
Eurofins Scientific Still Plans To More Than Double Its FCF By 2027
Eurofins is dealing with a revenue decrease due to the lack of COVID testing and the sale of reagents. Excluding the COVID-related revenue, the H1 2023 revenue would have increased by a high single di...
Eurofins Scientific SE. (ERFSF) Q1 2023 - Earnings Call Transcript
Eurofins Scientific SE. (ERFSF) Q1 2023 - Earnings Call Transcript.
Introduction To The Testing, Inspection, And Certification (TIC) Market
We present an overview of the testing, inspection, and certification (TIC) market. We highlight the different strategies that have been pursued by the main 4 players over time.
Eurofins Scientific SE (ERFSF) Q4 2022 Earnings Call Transcript
Eurofins Scientific SE (OTCPK:ERFSF) Q4 2022 Results Conference Call March 1, 2023 9:00 AM ET Company Participants Dr. Gilles Martin - Chairman and Chief Executive Officer Laurent Lebras - Chief Finan...
Eurofins Scientific: Short Term Pain, But Keep Your Eyes On The Long-Term Potential
Eurofins is a large life sciences company, but its COVID tailwinds are coming to an end. Apparently the market is surprised by this. I am not.
Eurofins Scientific: A Buy On Any Further Pullback
Eurofins Scientific printed cash during the COVID pandemic as its testing capacity was running at full utilization. There shouldn't be any massive post-COVID blues as growth in other domains should of...
Eurofins Scientific: Positive Capital Allocation Shifts Reinforce The Bull Case
Eurofins' latest buyback announcement comes on the heels of its first major divestment in years. Backed by a strong balance sheet, the company looks geared for more growth ahead.
Eurofins and Rite Aid Launch an Over-the-Counter, FDA-Authorised, at-Home COVID-19 PCR Test in all Rite Aid Locations in the U.S.
LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF), through its empowerDX subsidiary, and Rite Aid announce the launch of an over-the-counter, FDA-authorised[1], at-home COVID-19 PCR Test Kit. The co-b...
TruGraf Contracted With Humana for In-network Coverage of Medicare Kidney Transplant Patients
LUXEMBOURG--(BUSINESS WIRE)--Eurofins Transplant Genomics, Inc. (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide, is excited to announce...
Eurofins Subsidiary empowerDX and Uber Team up, Offer At-home COVID-19 Testing Kits via On-demand Delivery in More Than Two Dozen U.S. Cities
LUXEMBOURG--(BUSINESS WIRE)--Eurofins subsidiary, empowerDX, is working with Uber to offer FDA-emergency use authorized, at-home COVID-19 testing kits to consumers.
The Tell: Here are the top ‘high-conviction' buys for Q3 from star stock-pickers according to Morningstar
Research provider Morningstar is out with its list of the 10 most “high-conviction” purchases among “ultimate stock pickers,” and the results are a bit eclectic.